Grape Seed Extract May Lower Blood Sugar in Diabetes Mellitus
the Renal and Urology News take:
Grape seed extract may help to lower blood sugar and glucose levels in patients with diabetes mellitus, according to a Chinese study.
Researchers at the College of Food Science of Shenyang Agricultural University gave oral grape seed extract supplements to diabetic rats. Those that were given procyanidin fractions were compared to a controlled group that received none.
At six weeks, they found that the grape seed extract (procyanidin oligomers) was found to have a stronger anti-diabetic effect in rats with diabetes.
Previous studies have demonstrated that the resveratrol that is found in grape seed extract may help to ward off cancer, in addition to healing skin wounds, inhibiting oral sugar metabolism, slowing the growth of bacteria in dental infection, and improving liver function.
Patients with diabetes mellitus on a modified diet who are not currently taking anti-diabetic medications cannot manage their glucose levels normally, which can lead to hyperglycemia or high blood sugar.
Grape seed extract may help to lower blood sugar and glucose levels.
A new study conducted by Chinese researchers suggests grape seed extract supplements may lower blood sugar or glucose and serum lipids in patients with diabetes mellitus. Diabetes mellitus patients who do not take anti-diabetic medications and follow a modified diet cannot deal with glucose normally, leading to hyperglycemia or high blood sugar, which is the prime feature of diabetes mellitus.
In the study, some diabetic rats orally supplemented with grape seed extract - procyanidin fractions with different degrees of poymerizations were compared with diabetic rats that did not receive any treatment.
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)
Renal and Urology News Articles
- Iron-based Binder Improves Phosphorus Levels in Dialysis Patients
- Add-on Sevelamer Therapy May Improve Hemodialysis Patient Survival
- Type of Long-term Response to Targeted mRCC Therapy Affects Outcomes
- Hypothyroidism Tied to Worse Quality of Life for HD Patients
- Hyperphosphatemia May Predict Diastolic Dysfunction in CKD